The new PDA Education Hub has launched to offer a range of professional development courses and resources to help members to thrive and grow in their careers. The free resources will be exclusively available to PDA members to help them at all stages of their career; whether preparing for the pre-reg assessment, updating clinical knowledge or used [...]
The new NHS People Plan, published today, pledges to create a sustainable supply of prescribing pharmacists with enhanced clinical and consultation skills. NPA vice chair, Nick Kaye, said: “Only by mobilising the entire healthcare workforce, including community pharmacists and their teams, can there be any prospect of the NHS recovering from COVID-19 and [...]
A recent PDA survey has found that 4 in 10 community pharmacists who caught COVID-19 believe they caught it at work. As community pharmacy employers are yet to report a single case of an employee likely catching the virus at work, this raises serious questions as employees have a legal requirement to report such instances to the Health & Safety Executive [...]
Scotland’s high profile National Clinical Director of Healthcare Quality & Improvement has praised pharmacists for reaching out to vulnerable people during the coronavirus pandemic, but told them, “your work is not done”. Sharing latest virus statistics at the National Pharmacy Association’s online conference this week, Professor Jason Leitch warned that a second peak is [...]
The PDA recently held their 12th Annual General Meeting as a trade union where they revealed another record increase in membership numbers. Due to the pandemic, the meeting was the first general meeting of the union to be held virtually. At the Annual General Meeting, the PDA Union General Secretary, John Murphy reported another successful year [...]
The European Commission (EC) approval is based on the Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Phase III renal outcomes trial, which was stopped early based on the achievement of a pre-specified efficacy criterion. Canagliflozin is the first therapy approved in nearly 20 years to slow the progression of [...]
Community Pharmacy employers have not reported any cases of the COVID-19 infection amongst employees despite a regulatory requirement that they must report if there is reasonable evidence that someone diagnosed with COVID-19 was likely exposed because of their work. It is a reasonable assumption that pharmacists and their teams, in all areas of practice, will [...]
The PDA respond after the General Pharmaceutical Council (GPhC) issued a joint letter with the Competition and Markets Authority (CMA) regarding the alleged actions of some pharmacies during the coronavirus period. The PDA has previously highlighted how the GPhC identified over 650 major patient safety concerns in routine pharmacy inspections, but had not instigated any Fitness to [...]
Rosemont Pharmaceuticals will operate as an independent entity following acquisition a by Inflexion private equity. With more than 50 years’ experience and an extensive range of both licensed products and specials within the UK, Rosemont are the experts in liquid medicines with a portfolio of over 130 oral liquid medicines which includes over 70 licensed [...]
The PDA has launched a COVID-19 risk management tool designed to help responsible pharmacists and employers identify and remove risks in community pharmacy as lockdown restrictions are lessened. Mark Koziol, PDA Chairman said: "As the government has started to liberalise the lockdown, it is likely that the pharmacies will see even more activity. As healthcare [...]
